Pharmacokinetic properties of the beta-adrenergic receptor blocking drugs.
D000319:Adrenergic beta-Antagonists / Q000097:blood / Q000378:metabolism* / Q000494:pharmacology; D000328:Adult; D000526:Alprenolol / Q000378:metabolism; D001702:Biopharmaceutics; D001798:Blood Proteins / Q000378:metabolism; D002648:Child; D006207:Half-Life; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D007408:Intestinal Absorption; D007700:Kinetics; D008099:Liver / Q000378:metabolism; D008102:Liver Circulation / Q000187:drug effects; D010096:Oxprenolol / Q000378:metabolism; D010869:Pindolol / Q000378:metabolism; D011433:Propranolol / Q000378:metabolism; D011485:Protein Binding
D000319:Adrenergic beta-Antagonists; D001798:Blood Proteins; D010096:Oxprenolol; D000526:Alprenolol; D011433:Propranolol; D010869:Pindolol